BEIJING: Chinese researchers are testing mixing two COVID-19 vaccines developed by CanSino Biologics and a unit of Chongqing Zhifei Biological Products respectively, according to clinical trial registration data.
Earlier this month, the director of the Chinese Center for Disease Control and Prevention said the country was "formally considering" giving people COVID-19 vaccines developed with different technologies as a way of further boosting vaccine efficacy.
A trial expected to involve 120 participants will test the safety and ability to trigger immune response of a dose of CanSinoBIO's Ad5-nCoV treatment, followed by a dose of ZF2001 from Anhui Zhifei Longcom Biopharmaceutical, at 28-day or 56-day interval, according to clinical trial record site ClinicalTrials.gov maintained by a department under the National Institute of Health of the United States.
The trial, under way in the eastern Chinese city of Nanjing, is sponsored by disease control authorities in Jiangsu province, according to the record.
Both vaccines are included in China's mass vaccination drive.
CanSinoBIO said interim data from overseas Phase III clinical trials showed its Ad5-nCoV vaccine was 68.83% effective at preventing symptomatic COVID-19 disease two weeks after one injection, while the rate fell to 65.28% four weeks after one shot.
Chinese researchers are also running trials for two-dose-based vaccination of Ad5-nCoV, as well as an inhalation version of the vaccine.
No efficacy readings has been made available from Phase III trials for Zhifei Longcom's ZF2001 vaccine, which requires three injections when used on its own.
CanSinoBIO and Chongqing Zhifei Biological Products were not immediately available for comment.
Reuters
Mon Apr 19 2021
Chinese researchers are also running trials for two-dose-based vaccination of Ad5-nCoV, as well as an inhalation version of the vaccine. REUTERSpic
Malaysia amalkan dasar luar yang seimbang, elak provokatif - Anwar
Malaysia mengamalkan pendekatan dasar luar yang seimbang antara Barat dan Timur, selain mengelakkan sebarang keadaan yang dilihat sebagai provokatif, kata Perdana Menteri Datuk Seri Anwar Ibrahim.
Anjing kejar budak berjaya ditangkap, ada pemilik - PBT
Majlis Perbandaran Manjung (MPM) berjaya menangkap tiga ekor anjing yang dipercayai mengejar seorang kanak-kanak lelaki hingga nyaris digilis kereta pada Sabtu.
Fokus Minggu Depan: Soladiriti Gaza merantasi bangsa dan agama
Break The Siege: Fokus Minggu Depan membincangkan topik Solidariti Gaza Merentasi Bangsa dan Agama susulan penangguhan misi penghantaran bantuan ke Gaza anjuran Freedom Flotilla Coalition (FFC).
Boling padang: Daripada jaguh kampung, Farah Ain kini bergelar jaguh dunia!
Farah Ain berjaya menempatkan dirinya di puncak dunia dengan menggondol pingat emas perseorangan wanita di Kejohanan Boling Padang Dalam Dewan Dunia, Guernsey.
Kekejaman Zionis: Angka kematian meningkat ke lebih 34,000
Sekurang-kurangnya lapan rakyat Palestin terbunuh dan berpuluh-puluh cedera pada petang Jumaat dalam serangan Israel ke atas kem pelarian Nuseirat di tengah Gaza.
Pertumbuhan saksama: Penglibatan negara maju penting
Tengku Zafrul melihat kerjasama dan penglibatan negara maju sebagai aspek penting dalam membantu membawa kemampanan dan pertumbuhan yang seimbang.
PRK Kuala Kubu Baharu: Calon PH lancar manifesto minggu depan
Calon PH Pang Sock Tao akan melancarkan manifesto sempena PRK Kuala Kubu Baharu minggu depan.
SPRM siasat pemimpin kanan di utara tanah air
Seorang pemimpin kanan di utara tanah air disiasat Suruhanjaya Pencegahan Rasuah Malaysia (SPRM).
TH tanggung lebih RM350 juta kos tunai haji tahun ini
Lembaga Tabung Haji (TH) menanggung lebih RM350 juta membabitkan kos langsung dan tidak langsung tunai haji menerusi Bantuan Kewangan Haji pada tahun ini.
Musim haji: Persiap diri, jaga keselamatan dan kesihatan - Sultan Selangor
Sultan Sharafuddin menasihatkan jemaah agar membuat persiapan fizikal, emosi dan ilmu pengetahuan dengan sebaiknya.